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ABSTRACT 
Asthma is a complex disease which is due to the interaction 
of an unknown number of genes with strong environmental 
factors. Segregation analysis suggests the presence of major 
genes underlying asthma and atopy. Different genetic effects 
have been recognized which predispose to generalized 
atopy, or modify the atopic response to particular allergens, 
or enhance bronchial inflammation, or modify bronchial 
tone. These known genes or genetic loci do not account for 
all of the familial clustering of asthma and atopy. Many stud-
ies are now under way to identify the remaining genes.
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INTRODUCTION 
The familial nature of atopy and asthma implies that they are 
due, at least in part, to inherited genetic factors. Study of their 
genetics will first increase understanding of the aetiology and 
pathophysiology of these diseases. Second, it may be hoped 
that the early identification of children at genetic risk of asthma 
may open new approaches to the prevention of illness. Third, 
the involvement of particular genes may identify a particular 
clinical course and response to therapy. Fourth and perhaps 
most distantly, genetics may lead to new pharmacological treat-
ments for asthma. 
 Asthma is a complex disease that is likely to be due to the 
interaction of several genes with important environmental fac-
tors. In contrast to single gene disorders, such as cystic fibrosis 
or muscular dystrophy, genes predisposing to asthma will not 
contain mutations. Rather, as for genes influencing lipid metab-
olism, they will be variants of normal genes, whose evolutionary 
advantage has been lost in the current Western environment. 
  Asthma is almost certainly not one disease but many. In chil-
dren, 95% of asthma is allergic, also known as atopic. The term 
atopy, meaning 'strange disease', describes a familial syndrome 
of asthma, seasonal rhinitis (hay fever) and infantile eczema.
 Of the various types of asthma, atopic asthma is clinically 
most easily recognized and defined and has the most obvious 
familial clustering. For this reason, most effort towards elucidat-
ing the genetic causes of asthma have been directed at asthma 
in children and in young adults and at the underlying condition 
of atopy. 
 The identification of genes causing disease is through two 
processes: the study of candidate genes, or by genetic linkage 
and positional cloning. These two approaches, which will be 
described in more detail later, both begin with a definition 
of phenotype, which may be the disease itself or the choice of 
disease-related parameter (known as an intermediate pheno-
type). The choice of phenotype may be critical in the eventual 
ability to discover the genetic lesions or variations that predis-
pose to disease.
ASTHMA AND ATOPY PHENOTYPES
Asthma may be recognized by questionnaire, physical examina-
tion or the demonstration of a variable reduction of airflow. In 
the absence of an attack of asthma, airflow limitation can be 
demonstrated by challenge tests. Challenges in common use 
include exercise, cold air and inhaled bronchial spasmogens, 
such as histamine or methacholine. Of these challenges, spas-
mogen inhalation gives the most reliable measure of underlying 
airway lability. Challenge tests have been widely used in the 
investigation of asthma, both in the clinical setting and in large 
epidemiological surveys. 
 Atopy is distinguished by immunoglobulin E (IgE) responses to 
inhaled proteins, known as allergens. Typical allergen sources 
include house dust mite (HDM), grass pollens and animal dan-
ders. The total annual exposure to allergens is small, often in the 
order of micrograms. IgE binds by its high affinity receptor
(FcεRI) most notably to mast cells in the skin and in mucosol sur-
faces of the lung and intestines. Mast cells contain dense gran-
ules, which contain histamine and other inflammatory 
mediators, in addition to pro-inflammatory cytokines. In sensi-
tized individuals, exposure to an allergen produces cross-linking 
of IgE, the triggering of high affinity receptors and the release of 
mast cell granules. The subsequent inflammation is in two 
waves; the first is immediate and the second occurs some hours 
later. Inflammation produces airway narrowing with wheeze
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when occurring in the lung and sneezing and obstruction when 
it occurs in the nose. The regulation of IgE and of some compo-
nents of early and late inflammation are under the control of 
antigen-specific T cells. 
 The atopic state is detected most easily by skin prick tests. In 
these, the allergen, in a dilute solution, is placed on the skin and 
a superficial prick is made to introduce minute amounts of aller-
gen below the dermis. Sensitization and mast cell degranulation 
is detected by a weal, which is maximal after 10-15 min. A sig-
nificant weal is judged to be between 2 and 4mm greater in size 
than a negative control.
 Atopy may also be detected by elevation of the total serum IgE, 
or by elevation of serum IgE titres against common allergens. 
Elevation of antigen-specific IgE is detected by BAST or ELISA 
techniques. In Western populations, there is a close correlation 
between prick skin tests, specific IgE titres (RAST), the total serum 
IgE and symptoms of wheeze or rhinitis. Despite these close cor-
relations, the relationship between the variables is complex. 
 Atopy, defined by skin tests, is very common and has been 
shown in several large Western population samples to affect 
between 40 and 50% of young adults.1-3 The prevalence of 
asthma has risen steadily through this century.4 The prevalence 
of seasonal rhinitis also appears to have risen, although the evi-
dence for this is less clear. The reasons for these increases, 
which cannot be due to changes in the gene pool, must be 
environmental.
 Any trait as common as atopy cannot be considered abnor-
mal and it is obvious that the atopic state gives some advantage 
to those who carry it. The most likely evolutionary reason for 
atopy to exist is that IgE is particularly important in handling par-
asite infestations.5,6 In our society, we are now largely free of 
parasite infection, the implications of which are also discussed 
in the later section on environment.
FACTORS CONFOUNDING GENETIC STUDIES OF 
ATOPY
The high poulation prevalence of atopy may seriously confound 
genetic studies.7 If atopy is present in 40-50% of the popula-
tion, then one-fifth of marriages may be between two atopics. 
Any large pedigree is therefore likely to contain several atopy 
genes introduced through different individuals, instead of a sin-
gle abnormal gene introduced through one progenitor. If atopy 
was due to a single gene disorder, then many of the population 
would be homozygous. If, as is likely, more than one gene pre-
disposes to the syndrome, then many individuals will carry two 
or more of these genes. 
  The substantial prevalence of atopy means that great care 
has to be taken in the recruitment of families for genetic studies. 
Ascertainment by public appeals for families with asthma8 or 
with eczema9 produced samples in which 70 and 80%, respec-
tively, were atopic, with considerable loss of power to detect 
linkage.8 For this reason, in Oxford we now recruit families
either from population samples (i. e. complete ascertainment), 
r through a defined proband with atopic disease. 
 For the purposes of genetic investigations, it is necessary to 
decide which measures of the atopy or asthma phenotype 
should be studied. The total serum IgE is an attractive parame-
ter for genetic study, as it has well established normal values 
and, in large population surveys, correlates well with the pres-
ence of asthma. However, approximately 45% of the variation 
in the total serum IgE is attributable to the specific IgE (BAST) to 
HDM or grass pollen.10 When multiple regressions are carried 
out on population data, asthma and bronchial hyper-respon-
siveness are found to relate to variation in the specific IgE, most 
notably to HDM.10,11 Once specific IgE is taken into account, the 
residual total IgE does not correlate with the presence of 
asthma. The specific IgE, either detected indirectly by skin 
te ts or directly in the serum by BAST or ELISA techniques, may 
theref e be suitable for genetic analysis. Bronchial hyper-
responsiveness is a further intermediate phenotype that is cur-
rently being investigated.
 It is also possible to study asthma as the principal phenotype. If 
this is done, care needs to be taken that the asthma being investi-
gated is as clinically homogeneous as possible, which will usually 
mean the asthma of children and young adults. As there is no 
clear-cut division between normal and abnormal individuals, stud-
ies of asthma should exclude marginal phenotypes and should 
concentrate on 'barn door' affected and unaffected subjects. 
 Selection will affect the type of genetic effects found in partic-
ul r samples of subjects or families. Even if total or specific IgE 
is used as a phenotype, the factors influencing the IgE in asthma 
patients may be different from those affecting the IgE in children 
with eczema, or in subjects selected for the presence of positive 
skin tests rather than for symptoms. 
  The behaviour of atopy with age presents a particular prob-
lem for geneticists. While many diseases have increasing pene-
trance throughout life, atopy has a low penetrance in infancy, 
which rises to a maximum from 15 to 25 years of age. There-
after serum IgE and skin prick test responses decline steadily 
until, at the age of 45, the serum IgE may be half of its value at 
the age of 15.2
INHERITANCE OF ATOPY 
Geneticists have traditionally carried out segregation analysis 
as a first step in the study of a genetic disorder. Segregation 
analysis is intended to detect the presence of major genes pre-
disposing to the disease, or to suggest that the illness is poly-
genetic, or environmental, or a mixture of environmental and 
genetic factors. Segregation analysis may be used to estimate 
the values of parameters related to the mode of inheritance of a 
trait, its penetrance and its prevalence. Taken together, the esti-
mat s from segregation analysis make up a model that can be 
used o test for genetic linkage of a trait to particular chromoso-
al regions.
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 The pattern of inheritance of atopy has been the subject of 
much debate. In 1916, Cooke and Van der Veer, in a study of 
1000 patients, found that if one parent was allergic then 50% of 
children were similarly affected and that if both parents were 
allergic then, so too, were 75% of their children.12 This neat 
Mendelian finding was disputed by Schwartz, who found families 
in which atopic children had normal parents. He proposed a 
dominant model of inheritance tempered with incomplete pene-
trance.13 Weiner et al. observed a similar pattern in 1936.14 
 These early authors studied the inheritance of the whole syn-
drome without reducing it to its component parts. Later studies 
concentrated on the inheritance of specific illnesses, such as 
asthma or hay fever. In these circumstances a pattern of inheri-
tance was much harder to define. Sibbald and Turner-Warwick15 
studied the first degree relatives of atopic and non-atopic asth-
matics, mostly by questionnaire, and found some evidence of 
familial aggregation of atopy without any clear cut pattern of 
inheritance.15 Edfors-tubs studied 7000 twin pairs for asthma 
and atopy, relying primarily on responses to a questionnaire. She 
concluded that asthma was polygenic.16
 After atopy was shown to be mediated by IgE, workers then 
concentrated on the genetics of this parameter, as it was now 
quantifiable in a way that was not possible with symptoms alone. 
Bazaral et al. studied IgE levels in infants and mothers, conclud-
ing that there was simple Mendelian inheritance of basal IgE lev-
els.17 A subsequent study by the same investigators showed 
identical twins to be highly concordant for total serum IgE and 
that this effect was not linked to HLA haplotypes.18 The result indi-
cated an important genetic component to the control of total 
serum IgE. Hanson et al. studied pulmonary function, total serum 
IgE and specific IgE responses (BAST) in mono-zygotic and dizy-
gotic twins reared together and apart.19 He too found that 
monozygotic twins reared apart or together were concordant for 
total IgE, but that they differed in specific IgE responses. 
 Marsh and colleagues studied many families for the inheri-
tance of total IgE.20 They found that there was no simple pattern 
of Mendelian inheritance of the high IgE trait, but that a model 
in which high IgE was recessive best fitted the data. Gerrard et 
al. also studied many families with complex segregation analy-
sis, and concluded that a major locus controlled IgE levels with 
a recessive allele determining high IgE levels, but that other 
genes influenced the trait.21 Blumenthal et al., however, consid-
ered that a dominant allele coded for high IgE levels in some 
families while a recessive allele coded for the trait in others.22
 Borecki et al. studied a Canadian population for the inheri-
tance of atopy. They found that if the total serum IgE was the 
only measure of atopy, then an autosomal recessive pattern of 
inheritance best fitted the data.23 When they included symptoms 
in their definition, they then found that a dominant pattern of 
inheritance best explained their findings. 
 Using a definition of atopy that included responses to skin 
prick tests and serum specific IgE estimation in addition to total 
IgE (which they termed IgE responsiveness), Cookson and
Hopkin examined the genetics of atopy in a limited number of 
nuclear and extended families.24 Their findings suggested that 
there was a major genetic component to atopy. As with the kin-
dreds studied by Marsh, at least 10% of atopic subjects did not 
hav  atopic parents, which the authors attributed to dominant 
inheritance with incomplete penetrance.24 
 Thus, diverse models have been proposed for the inheritance 
of atopy at different times, with varying definitions of atopy and 
different methods of analysis. It is perhaps as a result of the diver-
sity of approaches that dominant, dominant with incomplete 
penetrance, recessive and polygenic modes of inheritance have 
all been suggested. None of these hypotheses explain the results 
of many studies that have shown the risk of atopy is much higher 
in hildren of atopic mothers than in children of atopic fathers. 
That asthmatic mothers had more asthmatic children than asth-
matic fathers was reported 60 years ago25 and large studies have 
shown a similar maternal pattern for the inheritance of elevations 
of the cord blood IgE,26,27 atopic symptoms28,29 and skin prick test 
spons s to common allergens.30 This finding may be due to 
interactions between the mother and child in utero, through the 
placenta, or post partum, through the breast milk. Genomic 
imprinting, in which a paternal 'atopy gene' may be suppressed 
during spermatogenesis, is also possible.31
 One new approach to the problem of a complex phenotype 
has b en the application of regressive models to segregation 
analysis. Despite close correlations between symptoms, total 
serum IgE and specific IgE, genetic effects independently modify-
ing hese different variables can be dissected out with these mod-
els. This type of segregation analysis has been applied to total 
serum IgE. The results demonstrate that, at least in the popula-
tion studied, total IgE is influenced by at least one gene that is 
independent of genes affecting skin tests or positive BAST tests.32 
 The failure to show a simple consistent model of inheritance is 
most simply explained by accepting that the most likely possibil-
ity is several genes interacting with a strong environmental com-
ponent. For the purpose of identifying genes causing atopy, an 
eclectic approach to phenotype definition is necessary, allowing 
fo  potential differences in the genes influencing skin tests and 
BAST, total serum IgE or disease states, such as asthma.
FINDING GENES 
As with other complex diseases, genes contributing to atopy 
may be found either by examining candidate genes or by 
genetic linkage. The enormous increase in the understanding of 
complex cytokine networks that influence atopy has meant that 
a plausible case could be put for as many as 20 different candi-
dates. The role of candidate genes may be assessed by defining 
polymorphisms within the respective genes and by testing for 
associations with disease. At the moment, a systematic search 
through the various candidates has not been carried out. Two 
candidates, IL-4 and the beta chain of the high affinity receptor
of IgE (FcεR/β), have been implicated by genetis linkage studies.
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 Genetic linkage relies on the demonstration of co-inheritance 
of disease and genetic markers of known chromosomal local-
ization. This approach has the advantage of not requiring any 
pre-existing knowledge of the pathophysiology of the disease. 
However, the power to detect linkage in multigenic diseases is 
very limited (Table 1), so that several hundred families may be 
necessary to detect linkage to a gene affecting one-third of sub-
jects with the disease. A further problem with complex diseases 
is that of replication of linkage.33 Linkage to a heterogeneous 
trait will normally only be found fortuitously in samples which 
contain an exceptional proportion of individuals or families 
influenced by that particular gene. Simulation experiments have 
shown that, in these circumstances, many studies may be neces-
sary before replication occurs.
GENES INFLUENCING ASTHMA AND ATOPY
Many different kinds of genes may be involved in atopy and 
asthma. These genes can be divided into four classes: 
Class I: Genes predisposing in general to IgE-mediated 
inflammation. 
Class II: Genes influencing the specific IgE response. 
Class III: Genes influencing bronchial hyper-responsiveness 
independently of atopy. 
Class IV: Genes influencing non-IgE mediated inflammation.
Class I asthma genes
Genes predisposing to generalized atopy have been identified 
on chromosomes 11 and 5 by a combination of genetic linkage 
and candidate gene approaches.
Chromosome 11q12-13
The first suggested linkage of atopy was to the marker d11s97 
on chromosome 11q13.34,35 Following some controversy,36 this 
linkage has been replicated by another two research 
groups.37,38 This linkage was confounded by the high preva-
lence of atopy and because the linkage was predominantly seen 
in maternal meioses.37,39 In the largest study described, linkage 
was exclusively maternal.39 The reasons for the maternal linkage 
are not known and it is not clear that this maternal phenomenon 
corresponds to the phenotypic maternal inheritance of atopy 
that has been previously noted. 
  Recognition of the maternal linkage allowed better localiza-
tion of the atopy locus, to within a 7cM one lod unit support 
interval.40,41 This interval was centromeric to and excluded the 
original d11s97 marker to which linkage was first observed. A 
lymphocyte surface marker, CD20, was noted to be within the 
interval. CD20 shows sequence homology to the beta chain of
the high offinity receptor for IgE(FcεR/β) and hos been iocalized
close to that gene on mouse chromosome 19.42 The human
FcεR/β was subsequently found to be on chromosome 11q13, in
Table 1. The power to detect linkage
   The table shows the number of affected sibling pairs required to detect loci at 
P=0.05 with 90% power at u=0.005, with different proportions of families linked 
to the putative locus. The required numbers of sib-pairs are estimated for three 
modes of inheritance. The table assumes 70% marker informativeness. (Table 
courtesy of Dr Alan Young, Statistical Genetics Group, Wellcome Centre for 
Human Genetic Disease, Oxford, UK.)
close genetic linkage to atopy.40 Two coding polymorphisms
have now been identified within the gene, FcεR/β Leu181 and
FcεR/β Leu181/Leu183.43 These both show strong associations
with atopy when maternally inherited. The population prevalence
of FcεR/β Leu181/Leu183 is approximately 4%44 Qnd FcεR/β
Leu181 has been reported in 15% of asthmatic patients.43
These results with FcεR/β variants have not been replicated out-
side of the Oxford group and a reliable assay system for the van-
ants has not yet been established. FcεR/β Leu181 does not show
functional differences from the wild-type receptor (JP Kinet, pers. 
comm. 1995). A further complication is the detection of a third
homologous gene, Htm4, in close proximity to FcεR/β and
CD20,45 so that it is not clear how many members of the gene fam-
ily are present. As it stands, it is therefore not yet established
whether the chromosome 11q atopy gene is FcεR/β or whether it is
some other gene in linkage disequilibrium with the FcεR/β variants.
Chromosome 5
Linkage of total serum IgE to markers near the cytokine cluster 
on chromosome 5g31-33 has been demonstrated by Marsh et 
al.46 Marsh and colleagues studied Amish pedigrees selected to 
contain members with positive skin prick tests. Linkage was, 
however, strongest in families with the lowest serum IgE. A link-
ag  to the same general region was found by Myers et al.47 in 
Dutch asthmatic families. The regions of linkage in these two 
studies may not coincide. Linkage has not been found in other 
studies of extended families (S Rich, pers. comm. 1995). My 
group have tested 1500 individuals from 300 nuclear families 
and have not found any evidence for linkage either by sib-pair 
or by lod score methods. However, in order to test the claim that 
linkage is predominantly seen with the low IgE phenotype, we 
have used class D regressive models to account for specific IgE 
r sponse. Residual IgE shows evidence of linkage to a 
microsatellite repeat found in IL4, but not to other polymorphic 
markers studied by Marsh or Myers (Dizier et al. unpubl. data, 
1996). We found no linkage to asthma or bronchial responsive-
ness at this locus. 
  The region contains a number of cytokines, the most impor-
tant f which, from the point of view of atopy, are IL-4, IL-13, the
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p40 subunit of IL-12 and IL-5. Other cytokines include IL-9 and 
granulocyte-colony stimulating factor (G-CSF). A substantial 
amount of work is now required to establish which of these var-
ious candidates accounts for the linkage.
Class II asthma genes 
Atopic individuals differ in the particular allergens to which they 
react. This difference is of clinical significance, as asthma and 
bronchial hyper-responsiveness are associated with allergy to HDM 
but not to grass pollens.10,11 It is therefore of interest to examine 
whether particular genes influence the IgE response to specific 
allergens. In addition, study of these genes may give an insight into 
the inheritance of normal variation within the immune system and 
the functional consequences of such variation. 
 There are two classes of genes that are likely candidates for 
constraining specific IgE reactions. These are the genes encod-
ing the human leucocyte antigen (HLA) proteins and the genes 
for the T-cell receptor (TCR). These modules are central to the 
handling and recognition of foreign antigens.
Inhaled allergen sources, such as HDM, are complex mixtures
of many proteins. A number of 'major allergens' to which IgE
responses are consistently found in most individuals have been
identified from each allergen source. It is likely that genetic asso-
ciations will be better detected with reactions to purified major 
allergens rather than with complex allergen sources. Major aller-
gens include Der pI (25.4kDa) and Der pII (14.1kDa) from the 
HDM Dermatophagoides pteronyssinus, Alt al (28 kDa) from the
mould Alternaria alternata, Can fI (25kDa) from the dog Canis 
familiaris, Fel dI (18kDa) from the cat Felis domesticus and Phi 
pV (30kDa) from Timothy grass (Phleum pratense).
Human leukocyte antigen 
The human major histocompatibility complex (MHC) includes 
genes coding for HLA class II molecules (HLA-DR, DQ and DP), 
which are involved in the recognition and presentation of 
exogenous peptides. 
 An HLA influence on the IgE response was first noted by Levine 
et al.48 who found an association between HLA class I ha.plotypes 
and IgE responses to antigen E derived from ragweed (Ambrosia 
artemisifolia) allergen. This association has been subsequently 
found to be due to the restriction of the response to a minor com-
ponent of ragweed antigen (Amb a V) by HLA-DR2.49 To date, the 
association of Amb a V (molecular weight 5000) and HLA-DR2, is 
the only HLA association to have been consistently confirmed.4a-50 
Other suggested associations are of the rye grass antigens Lol p I, 
LoI p II and LoI p III with HLA-DR3 (in the same 53 allergic sub-
jects),51,52 American feverfew (Parthenium hysterophorus) and 
HLA-DR3 in 22 subjects from the Indian sub-continent,53 the IgE 
response to Bet v I (the major allergen of birch pollen) and HLA-
DR3 in 37 European subjects54 and an HLA-DR5 association with 
another ragweed antigen Amb a VI in 38 subjects.55
 Other authors have reported negative associations with par-
ticular allergens. These include HLA-DR4 and IgE responses to 
mountain cedar pollen (37 subjects)56 and HLA-DR4 and melit-
tin (from bee venom; 22 subjects).57 Non-responsivenes to 
Japanese cedar pollen may be associated with HLA-DQw8.58 
  There is, to date, no confirmation of many of these results and 
the number of subjects has generally not approached that 
requir d to establish an unequivocal HLA association. In addi-
tion, there has not been recognition of the problems of reactiv-
ity to multiple allergens: significant relationships between 
HLA-DR alleles and five antigens (Amb a V, LoI pI, Loi pII, Lol p 
III and Amb a V) have been claimed from the same pool of 
approximately 200 subjects.49,51,52,55
 In order to test more definitively if HLA class II gene products 
have a general influence on the ability to react to common aller-
gens, we have genotyped for HLA-DR and HLA-DP in a large 
ample of atopic subjects from the British population.59 Subjects 
were t sted for IgE responses to the most common British major 
allergens. 
 Four hundred and thirty-one subjects from 83 families were 
genotyped at the HLA-DR and HLA-DP loci and serotyped for 
IgE responses to six major allergens from common aero-
allergen sources. Three hundred subjects were used as controls. 
The subjects and controls have come from the same relatively 
homogeneous population. In the United Kingdom and Europe, 
allergens other than Bet v I and those tested for in our study are 
uncommon causes of sensitization and IgE-mediated allergy.
 The results showed only weak associations between HLA-DR 
allele frequencies and IgE responses to common allergens. A 
possible excess of HLA-DR1 was found in subjects who were 
responsive to FeI d I compared with those who were not [Odds 
Ratio (OR)=2; P=0.002]) and a possible excess of HLA-DR4 
was found in subjects responsive to Alt a I (OR=1.9; P=0.006). 
Increased sharing of HLA-DR/DP haplotypes was seen in sibling 
pairs responding to both allergens. Der p I, Der p II, Phi p V and 
Can f I were not associated with any definite excess of HLA-DR 
alleles. No significant correlations were seen with HLA-DP 
genotype and reactivity to any of the allergens.
 Of all possible associations, that of Alt a I with HLA-DR4 and of 
Fel d I with HLA-DR1 were supported by a finding of excess shar-
ing of a HLA haplotype in affected sibling pairs. Regression analy-
sis showed that the apparent association of Phi p V with HLA-DR4 
was due to the presence of many individuals who reacted with an 
IgE response to both Alt a I and Phi p V. The association of HLA-
DR1 and Fel d I is the strongest statistically and is significant even 
taking the multiple comparisons into account. 
 The study was the first to investigate HLA-DP alleles and reac-
tivity to common allergens. As no definite correlation was found 
betwee  any antigen response and HLA-DP genotypes with sub-
stantial numbers of subjects, HLA-DP genes are unlikely to have 
a major role in restricting IgE responses to these allergens. 
 The results suggest that HLA-DR alleles do modify the ability 
to mount an IgE response to particular antigens. However, the
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OR for the association of Alt a I with HLA-DR4 was only 1.9 
while that of Fel d I with HLA-DR1 was 2.0. Thus, class II HLA 
restriction seems insufficient to account for individual differences 
in reactivity to common allergens. It is therefore likely that envi-
ronmental factors or other loci, such as T-cell receptor genes, 
may be of greater relevance in determining an individual's sus-
ceptibility to specific allergens.
T-cell receptor
The T-cell receptor (TCR) is usually made up of α and β chains,
although 5% of receptors consist of γ and chains. The β chain
locus is on chromosome 7 and the α chain locus is on chromo-
some 14. The δ chain genes are found within the α chain locus.
 An enormous potential for TCR variety follows from the pres-
ence of many variable (V) and functional (J) segments within
the TCR loci. However, the usage of the TCR Vα and Vβ seg-
ments by lymphocytes is not random and may be under genetic 
control 60-63
 
In order to examine if the TCR genes influence susceptibility to 
particular allergens, we have tested for genetic linkage between
IgE responses and microsatellites from the TCR-α/δand TCR-β
regions.64 Two independent sets of families, one British and one 
Australian, were investigated. Because the mode of inheritance 
was unknown and because of interactions from the environment 
and other loci, affected sibling pair methods were used to test 
for linkage.
Linkage of IgE serotypes to TCR-β was not detected, but sig-
nificant linkage of IgE responses to the HDM allergens Der p 
and Der p II, the cat allergen Fel d I and total serum IgE to TCR-
α was seen in both family groups. The results show that a locus
in the TCR-α/δ region is modulating IgE responses. The close
correlation between total and specific IgE makes it difficult to 
determine if the locus controls specific IgE reactions to particu-
lar allergens or confers generalized IgE responsiveness. Never-
theless, linkage was strongest with highly purified allergens, 
suggesting that the locus primarily influences specific responses. 
The pattern of allele sharing seen with some serotypes suggests 
a recessive genetic effect, making it possible that this linkage 
corresponds to the recessive atopy locus implied by previous 
segregation analyses.32,65
 Replication of positive results of linkage in a second set of 
subjects is important in interpreting this study. Differences
between the populations for the serotypes showing TCR-α allele
sharing may be due to different allergen exposures, as grass 
pollen responses were much more common in Australian sub-
jects. In addition, British subjects were recruited through clinics, 
whereas Australian subjects were not selected by symptoms. 
  No association was seen between particular IgE responses
and specific TCR-α microsatellite alleles, implying that the
microsatellite is not in immediate proximity to the IgE modulat-
ing elements. The degree of linkage disequilibrium across the
TCR-α/δ locus seems low66 and the microsatellite has only been
localized within a 900kb yeast artificial chromosome.67 The 
observed linkage may, therefore, be with any elements of TCR-
α or TCR-δ, or with other genes inthe locality.
Several Vα genes have been recognized to be polymorphic68
and limitation of the response to an allergen may correspond to
these polymorphisms. Particular TCR-Vα usage may induce IL-4
dominant (Th2) helper T cells, which enhance IgE production.69
A reported non-random usage of Vα 13 in Lol p I specific T-cell
clones supports independently the possibility of Vα genes con-
trolling IgE responses 70
  The TCR-δ locus is also a candidateforthis linkage. The func-
tion of TCR-γ/δ cells is not known, but their lotation on mucosol
surfa es, where allergens initiate IgE responses, could suggest a 
role in IgE regulatio .71
 This study has, therefore, identified a further genetic locus 
affec ing atopy. The genetic restriction of specific IgE responses 
may be of cli ical significance and may be of general interest in 
understanding the control of humoral immunity. Further localiza-
tion of this genetic effect requires the identification of TCR-α/δ
elements showing allelic associations with specific IgE responses. 
Studies are also needed to investigate the interactions between 
this chromosome 14 linkage and the HLA class II genes.
Class III asthma genes
No g nes have yet been identified that predispose to bronchial 
hyper-responsiveness independently of atopy. Variants in the 
beta adren rgic receptor have been identified and it has been 
suggested that these may be associated with nocturnal asthma 
or other subdivisions of the asthma phenotype.72
Class IV asthma genes
Airway inflammation is a characteristic of asthma that may be 
ind p ndent of mechanisms controlling atopy. Tumour necrosis
fac+or alpha (TNF-α) is a potent pro-inflammatory cytokine that
shows constitutional variations in the level of secretion which are 
linked to polymorphisms in the TNF gene complex,73-75 We 
have, therefore, investigated TNF polymorphisms for associa-
tion with asthma in 800 normal and abnormal subjects from the 
general population and from asthma clinic samples. We have 
found that asthma was significantly increased in subjects with
alleles associated with increased secretion of TNF-α, most
notably the TNF-α promoter polymorphism TNFα-308.
Considering unrelated subjects only (the parents) from both 
populations, the OR for asthma in individuals homozygous for 
the high secretor allele was 3.9 compared with homozygotes for 
the low secretor alleles (95% Cl 1.4-11.0; P=0.007).76
In the Japanese population, it is possible that a common 
mutation i  platelet activating factor acetylhydrolase predis-
poses to asthma,77 but this has not yet been confirmed in large 
datasets nor has it been linked to a structural change in the 
gene. This gene is, however, an excellent candidate for predis-
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posing to asthmatic airway inflammation in both Japanese and 
Western populations.
WHOLE GENOME SCREENS FOR ATOPY AND ASTHMA
The four loci described above do not account for all atopy. The 
chromosome 5 gene does not seem to have major effects on
the population as a whole and HLA and TCR-α loci modify the
specific response rather than endowing any general predisposi-
tion to atopy. Segregation analysis is unable to predict with any 
accuracy the number and nature of genes contributing to atopy 
and asthma. In order to discover if atopy is a genuine polygenic 
disorder, my group have performed a complete genome screen 
in 80 nuclear families, with 300 markers spaced at approxi-
mately 10% recombination. Using sib-pair analysis we have dis-
covered potential new linkages (P<0.001) to serum IgE or other 
asthma-associated phenotypes. These results are currently 
being evaluated for their significance in further sets of subjects. 
Similar large scale genome scans are to be carried out in the 
United States and Canada, so that it is likely general agreement 
will soon be reached on the number and nature of the most 
important loci causing atopy.
GENES AND ENVIRONMENT 
No description of the genetics of asthma would be complete 
without some consideration of the effects of environment. It is 
self-evident that in the absence of environmental precipitants 
allergic asthma and hay fever would not exist. Such conditions 
are found on mountains, where there is little pollen and where 
the low humidity prevents HDM growth. School children raised 
at high altitudes develop fewer allergies than those raised at sea 
level.78 Similarly, children living in the dry interior of Australia 
develop fewer allergies than those living in more humid condi-
tions near the coast.4
  Data from a number of sources indicate that events in early 
infancy are critical in determining the subsequent course of 
allergic disease. In Scandinavian countries, a short intense 
spring flowering of birch trees is accompanied by symptoms in 
many individuals. Children born in the 3 months around the 
pollen season carry an increased risk of allergy to birch pollen 
for the rest of their life.79 In English children, the level of HDM in 
infants' bedding during the first year of life correlates with the 
subsequent risk of childhood asthma.80 
 The enormous increase in the prevalence of asthma in the 
past two decades cannot be attributed to changes in gene fre-
quencies in affected populations and must be due to an en-
vironmental factor or factors. Air pollution has been suggested 
as a cause of this increase, although atmospheric pollution has 
declined steadily since the 1950s in England and Western 
Europe and ozone levels remain stable despite an increase in 
the number of cars. Comparative studies of the prevalence of 
asthma have been carried out between East and Wesi
Germany, two regions with genetically similar populations, but 
with far higher levels of atmospheric pollution in the East.81 
Surprisingly, the prevalence of asthma is lower in the East than it 
is in the West. This decrease is matched by a lower prevalence 
of atopy, as detected by skin tests to common allergens.82 
Similar results are seen when the prevalence of asthma in the 
Baltic States is compared to that of Sweden.83 This difference 
may be attributable to childhood respiratory infections, as 
polluti n and overcrowding, both of which are more common 
in the East, predispose to infantile infection. Support for this 
hypothesis is given by the finding that the youngest children in 
large sibships have significantly less asthma than their older sib-
lings.84 At the cellular level it is suggested that early infections 
program the immature immune system towards a Th-1 rather 
than a Th-2 helper cell profile, thereafter favouring a cellular 
rather than humoral immune response.
 Thus, even in genetically similar people, the dose and timing 
of all rgen exposure will have important effects on subsequent 
manifestations of the atopy phenotype. This places an addi-
tional requirement for careful study design and interpretation in 
atte pt  to unravel the genetics of atopic disease. 
 Another environmental factor to consider is that of parasitism. 
Slum-dwelling Venezuelan children have higher levels of serum 
IgE and lower levels of asthma than their more affluent compatri-
ots.8s In endemically parasitized Australian Abori-gines, the pres-
ence of a positive RAST to HDM correlates poorly both with skin 
test responses to the same allergen and the presence of 
asthma.86 Multiple regression shows that the discrepancy 
between RAST and skin tests is accountable by the elevation of 
total serum IgE. The results fit the hypothesis that parasitism, by 
causing an increase in polyclonal IgE, is protective against atopy.
SCREENING 
The increase in the prevalence of asthma in recent decades has 
a  important corollary: asthma is preventable. Recognition of 
children or infants genetically predisposed to asthma is likely to 
be the first step in strategies for prevention by environmental 
manipulation or vaccination in the first year of life. It is likely that 
many genetic variants that predispose to asthma will be identi-
fied i  the near future and that a comprehensive estimation of 
genetic risk to a particular infant will be feasible by the end of 
the decade.
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